IGF1R and small cell lung carcinoma: Inhibition of IGF1R (Insulin-like growth factor receptor 1) has been found to be efficacious together with etoposide and cisplatin in small-cell lung cancer [33] and further clinical trials are undergoing with other drugs and cancer types.